← All signal stories
§ SignalMay 20, 2026 · Issue 48 · Story 8

Three Years of Daily BCI Use Reframes Speech Neuroprosthetics as a Deployment Problem

Casey Harrell's multi-year ALS implant record shifts the BCI field's benchmark from lab demos to longitudinal real-world performance.

8. Three Years of Daily BCI Use Reframes Speech Neuroprosthetics as a Deployment Problem

Casey Harrell, an ALS patient fully paralyzed by his disease, has used a speech brain-computer interface continuously for nearly three years, accumulating thousands of hours of real-world operation. The system, developed by a research team and implanted in 2023, decodes intended speech from cortical electrode signals and converts them into audible output. MIT Technology Review's profile, published this week, describes Harrell as "the first power user" of the technology, a label that signals something the field has rarely been able to claim: sustained, independent, daily deployment rather than controlled lab sessions.

That distinction matters strategically. The dominant players in BCI commercialization, Neuralink, Synchron, and BrainGate's academic consortium, have all produced compelling short-window demonstrations, but longitudinal performance data at this scale has been scarce. Harrell's record reframes the competitive question. The bottleneck in speech neuroprosthetics is no longer whether decoding works in a lab; it is whether systems hold signal quality, decoding accuracy, and usability across years of continuous wear. Any company that can show multi-year stability data now owns a differentiated clinical argument. Synchron, whose Stentrode device has the least invasive implant profile, has a particular incentive to respond with equivalent longitudinal evidence.

The broader pattern is familiar from other hardware-adjacent AI categories: early capability demos compress into commodities faster than deployment durability does. Battery life defined smartphones after processing speed stopped differentiating them. In BCI, electrode longevity, firmware update cycles, and caregiver-independent operation may prove more decisive than raw decoding benchmarks. The next data point to watch is whether Harrell's research team publishes quantitative accuracy and signal-quality metrics across the full three-year window, which would give the field its first real longitudinal baseline.

Source: MIT Technology Review